Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome
- 9 December 2002
- journal article
- case report
- Published by Wiley in Clinical Endocrinology
- Vol. 57 (6), 827-831
- https://doi.org/10.1046/j.1365-2265.2002.01660.x
Abstract
Necrolytic migratory erythema (NME), the characteristic rash associated with the glucagonoma syndrome, is a cause of substantial morbidity among patients with this rare malignancy. Treatment options are suboptimal, and often useful for only short or moderate durations. We report the effective, long‐term (> 1 year) use of intermittent infusions of amino acids (AA) and fatty acids (FA) administered via peripheral intravenous access for the treatment of NME in the glucagonoma syndrome. Despite resolution of the NME, serum amino acid (initially subnormal) and fatty acid (initially normal) levels remained unchanged. Tumour growth and other symptoms related to the glucagonoma syndrome appear unaffected by such infusions.Keywords
This publication has 12 references indexed in Scilit:
- Successful treatment of a patient with octreotide-resistant necrolytic migratory erythemaBritish Journal of Dermatology, 1996
- Successful treatment of a patient with octreotide–resistant necrolytic migratory erythemaBritish Journal of Dermatology, 1996
- The Glucagonoma Syndrome Clinical and Pathologic Features in 21 PatientsMedicine, 1996
- Treatment of necrolytic migratory erythema in glucagonoma syndromeJournal of the American Academy of Dermatology, 1991
- Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acidsBritish Journal of Dermatology, 1991
- Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*Journal of Clinical Endocrinology & Metabolism, 1991
- Increased amino acid clearance and urea synthesis in a patient with glucagonoma.Gut, 1990
- Octreotide (SMS 201-995) in the Treatment of Metastatic Glucagonoma: Report of One Case and Review of the LiteratureDigestion, 1989
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995The New England Journal of Medicine, 1986
- CUTANEOUS MANIFESTATIONS OF INTERNAL MALIGNANT TUMORSArchives of Dermatology, 1942